VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, December 31, 2025

Stock Comparison

VeriSign, Inc. vs West Pharmaceutical Services, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

VeriSign, Inc.

VRSN · Nasdaq Global Select Market

Market cap (USD)
SectorTechnology
CountryUS
Data as of2025-12-31
Moat score
100/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into VeriSign, Inc.'s moat claims, evidence, and risks.

View VRSN analysis

West Pharmaceutical Services, Inc.

WST · New York Stock Exchange

Market cap (USD)
SectorHealthcare
CountryUS
Data as of2025-12-22
Moat score
85/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into West Pharmaceutical Services, Inc.'s moat claims, evidence, and risks.

View WST analysis

Comparison highlights

  • Moat score gap: VeriSign, Inc. leads (100 / 100 vs 85 / 100 for West Pharmaceutical Services, Inc.).
  • Segment focus: VeriSign, Inc. has 1 segment (100% in Naming Services (.com and .net registry)); West Pharmaceutical Services, Inc. has 2 segments (80.7% in Proprietary Products).
  • Primary market structure: Monopoly vs Quasi-Monopoly. Pricing power: Strong vs Moderate.
  • Moat breadth: VeriSign, Inc. has 4 moat types across 4 domains; West Pharmaceutical Services, Inc. has 5 across 3.

Primary market context

VeriSign, Inc.

Naming Services (.com and .net registry)

Market

Registry operator services for .com and .net top-level domains (domain registrations + authoritative DNS resolution)

Geography

Global

Customer

ICANN-accredited domain registrars (wholesale) and, indirectly, registrants

Role

Registry operator / DNS infrastructure provider

Revenue share

100%

West Pharmaceutical Services, Inc.

Proprietary Products

Market

Injectable primary packaging components and containment/delivery systems (elastomeric stoppers, seals, plungers, syringe/cartridge components; related services)

Geography

Global

Customer

Biologic, generic, and pharmaceutical drug manufacturers

Role

Primary packaging and delivery component supplier

Revenue share

80.7%

Side-by-side metrics

VeriSign, Inc.
West Pharmaceutical Services, Inc.
Ticker / Exchange
VRSN - Nasdaq Global Select Market
WST - New York Stock Exchange
Market cap (USD)
n/a
n/a
Sector
Technology
Healthcare
HQ country
US
US
Primary segment
Naming Services (.com and .net registry)
Proprietary Products
Market structure
Monopoly
Quasi-Monopoly
Market share
100% (reported)
70%-75% (reported)
HHI estimate
10,000
n/a
Pricing power
Strong
Moderate
Moat score
100 / 100
85 / 100
Moat domains
Legal, Network, Supply, Financial
Demand, Legal, Supply
Last update
2025-12-31
2025-12-22

Moat coverage

Shared moat types

Operational Excellence

VeriSign, Inc. strengths

Concession LicenseDe Facto StandardFloat Prepayment

West Pharmaceutical Services, Inc. strengths

Design In QualificationCompliance AdvantageBrand TrustCapex Knowhow Scale

Segment mix

VeriSign, Inc. segments

Full profile >

Naming Services (.com and .net registry)

Monopoly

100%

West Pharmaceutical Services, Inc. segments

Full profile >

Proprietary Products

Quasi-Monopoly

80.7%

Contract-Manufactured Products

Competitive

19.3%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.